Cart
sales@molnova.com
EST64454
CAS No. 1950569-11-5
EST64454( —— )
Catalog No. M22978 CAS No. 1950569-11-5
EST64454 is a highly soluble σ1 receptor antagonist (Ki : 22 nM),has the potential for Pain Management.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 174 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 671 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1251 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEST64454
-
NoteResearch use only, not for human use.
-
Brief DescriptionEST64454 is a highly soluble σ1 receptor antagonist (Ki : 22 nM),has the potential for Pain Management.
-
DescriptionEST64454 is a highly soluble σ1 receptor antagonist (Ki : 22 nM),has the potential for Pain Management.
-
In Vitro——
-
In VivoEST64454 (10 mg/kg; p.o.; male Wistar rats) treatment shows the Cmax, t1/2, AUC0-∞, Vss and F% are 771 ng/mL, 3.4 hours, 1431 ng h/mL, 4.4 l/kg and 69%, respectively.EST64454 (10 mg/kg; p.o.; male CD1 mice) treatment shows the Cmax, t1/2, AUC0-∞, Vss and F% were 1178 ng/mL, <1 hours, 2645 ng h/mL, 1.2 l/kg and 60%, respectively. Animal Model:Male Wistar rats (250-300 g) Dosage:10 mg/kg Administration:P.o. (Pharmacokinetic Analysis) Result:The Cmax, t1/2, AUC0-∞, Vss and F% were 771 ng/mL, 3.4 hours, 1431 ng h/mL, 4.4 l/kg and 69%, respectively.
-
Synonyms——
-
PathwayAutophagy
-
TargetSigma receptor
-
Recptorσ1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1950569-11-5
-
Formula Weight400.85
-
Molecular FormulaC18H23ClF2N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 100 mg/mL (249.47 mM))
-
SMILESCC(N1CCN(CCOCC2=NN(C3=CC=C(F)C(F)=C3)C=C2)CC1)=O.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Glycerol phenylbutyr...
Glycerol phenylbutyrate (GPB) is a new generation ammonia scavenger drug and it also is a sigma-2 (σ2) receptor ligand (pKi: 8.02).Glycerol phenylbutyrate may have therapeutic potential in additional conditions such as chronic hepatic encephalopathy or other inherited metabolic disorders. Glycerol phenylbutyrate also has the potential for the treatment of hyperammonemia.
-
Lu-28-179
Siramesine(Lu 28-179) hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of Y cells and to exhibit a potent anticancer activity in vivo.
-
AF-710B
AF-710B is a specific variant of M1 muscarinic and Sigma-1 receptor agonist used in the study of neurological disorders such as Alzheimer's disease dementia and schizophrenia.
